Study number 779857
Healthy Adults, age 18-65
Dates
Apr 26 2026-Jul 06 2026
Group
C10
Location
Dallas, Texas
Age
18-65
Gender
Male and Female
Smoker
Yes
Compensation
$12,049
Referral
$350
Study Details
This is a research study for a drug approved by the U.S Food and Drug Administration (FDA) for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. This study drug is also being developed for the potential treatment of autoimmune diseases, conditions in which the immune system mistakenly attacks the body.
Dallas, TX is currently recruiting Healthy Adults, ages 18-65.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
- Women can be of childbearing potential or non-childbearing potential.
Smoking Criteria
- Smoking is allowed.
Body Mass Index
- Participants must have a BMI of:
- 18-34
Screening procedures
- Screening procedures for this study may include:
- Vitals
- Physical examination
- Electrocardiogram (ECG)
- Collection of blood samples
- Drug and Alcohol testing
Additional Details
Check-in: Apr 26
Check-out: April 27
Follow-up visits: May 1, 4, 7, 11, 18, 25, Jun 8, 22, Jul 6,
Phone calls: Jun 1,15, 29